Effects of proton beam irradiation on uveal melanomas: A comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas

British Journal of Ophthalmology

Volumn 84, Issue 1, 2000, Pages 98-102

  Chiquet, Christophe ^a   Grange, Jean Daniel ^a   Ayzac, Louis ^a   Chauvel, Pierre ^b   Patricot, Louis Marc ^a   Devouassoux Shisheboran, Mojgan ^a  

^a UNIVERSITÉ DE LYON   (France)

^b Department of Radiotherapy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; ENUCLEATION; FEMALE; FIBROSIS; GLAUCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MITOSIS RATE; PRIORITY JOURNAL; PROTON RADIATION; THROMBOSIS; TUMOR VOLUME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MELANOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASM PROTEINS; PROTONS; STATISTICS, NONPARAMETRIC; UVEAL NEOPLASMS;

EID: 0034018350     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.1.98     Document Type: Article

References (36)

1. Egan K, Seddon JM, Glynn RJ, et al. Epidemiological aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-51.
2. Gamel JW, McLean IW. Computerized histopathological assessment of malignant potential. Cancer 1983;52:1032-8.
3. McLean IW, Gamel JW. Prediction of metastasis of uveal melanoma: comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA. Invest Ophthalmol Vis Sci 1988;29:507-11.
4. Seddon JM, Polivogianis L, Hsieh CC, et al. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as pronostic factors. Arch Ophthalmol 1987;105:801-6.
5. Shields J, Shields C. Management of posterior uveal melanoma. In: Intraocular tumors: a text and atlas. New York: WB Saunders, 1992:171-206.
6. Ghazvini S, Kroll S, Char DH, et al. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Invest Ophthalmol Vis Sci 1995;36:2762-7.
7. Coleman K, Baak JPA, van Diest PJ, et al. DNA ploidy status in 84 ocular melanomas. A study of DNA quantification in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Hum Pathol 1995;26: 99-105.
8. Meecham WJ, Char DH. DNA content abnormalities and prognosis in uveal melanoma. Arch Ophthalmol 1986;104: 1626-9.
9. Chen TC, Char DH, Waldman F, et al. Flow cytometry measurement of nuclear RNA content in uveal melanoma. Ophthalmic Res 1990;22:187-93.
10. Mooy C, Vissers K, Luyten G, et al. DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation. Br J Ophthalmol 1995;79:174-7.
11. Karlsson M, Boeryd B, Carstensen J, et al. DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas. Br J Cancer 1995;71:177-81.
12. Bardenstein DS, Char DH, Kaleta-Michaels S, et al. Ki-67 and bromodeoxyuridine labeling of human choroidal melanoma cells. Curr Eye Res 1991;10:479-84.
13. Pe'er J, Gnessin H, Shargal Y, et al. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation post-irradiation groups. Ophthalmology 1994;101:56-62.
14. Seregard S, Oskarsson M, Spangberg B. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma. Invest Ophthalmol Vis Sci 1996;37:1451-8.
15. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
16. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133: 1710-15.
17. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
18. Karlsson M, Boeryd B, Carstensen J, et al. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer 1996;32:357-62.
19. Schilling H, Sehu KW, Lee WR. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Invest Ophthalmol Vis Sci 1997;38:2081-92.
20. Seregard S, Lundell G, Lax I, et al. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma. Acta Ophthalmol Scand 1997;75:148-54.
21. Coupland SE, Bechrakis N, Schüler A, et al. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Br J Ophthalmol 1998;82:961-70.
22. McLean IW, Foster WD, Zimmerman LE, et al. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-9.
23. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparaison between ABC and unlabeled (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
24. Char DH, Huhta K, Waldman F. DNA cell cycle studies in uveal melanoma. Am J Ophthalmol 1989;107:65-72.
25. Seregard S, Spangberg B, Juul C, et al. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998; 105:485-91.
26. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplams. J Pathol 1990;162:285-94.
27. Mooy CM, de Jong PT, Van der Kwast TH, et al. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy. Ophthalmology 1990;97:1275-80.
28. Mooy CM, Luyten GP, de Jong PT, et al. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma. Am J Pathol 1995;147:1097-104.
29. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-92.
30. Diener-West M, Hawkins BS, Markowitz JA, et al. A review of mortality from choroidal melanoma. II A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992;110:245-50.
31. Khalil MK. Balloon cell malignant melanoma of the choroid: ultrastructural studies. Br J Ophthalmol 1983;67: 579-84.
32. Saornil MA, Egan KM, Gragoudas ES, et al. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol 1992;110:1112-18.
33. Uffer S. Ultrastructure of proton beam irradiated intraocular melanomas. In: Tumors of the eye. Amsterdam/New York: Kugler, 1991:525-52.
34. Saornil MA, Fisher MR, Campbell RJ, et al. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol 1997;115:1395-400.
35. Oterstag CB, Volk B, Shibata T, et al. The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours. Acta Neurochir 1987;89:117-21.
36. Schwarting R, Gerdes J, Niehus J, et al. Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki67. J Immunol Meth 1986;90:365-71.